Estrogen and neuroprotection: from clinical observations to molecular mechanisms.

Abstract:

:We now appreciate that estrogen is a pleiotropic gonadal steroid that exerts profound effects on the plasticity and cell survival of the adult brain. Over the past century, the life span of women has increased, but the age of the menopause remains constant. This means that women may now live over one third of their lives in a hypoestrogenic, postmenopausal state. The impact of prolonged hypoestrogenicity on the brain is now a critical health concern as we realize that these women may suffer an increased risk of cognitive dysfunction and neurodegeneration due to a variety of diseases. Accumulating evidence from both clinical and basic science studies indicates that estrogen exerts critical protective actions against neurodegenerative conditions such as Alzheimer's disease and stroke. Here, we review the discoveries that comprise our current understanding of estrogen action against neurodegeneration. These findings carry far-reaching possibilities for improving the quality of life in our aging population.

authors

Dubal DB,Wise PM

subject

Has Abstract

pub_date

2002-06-01 00:00:00

pages

149-61

issue

2

eissn

1294-8322

issn

1958-5969

journal_volume

4

pub_type

杂志文章
  • Imaging genetics of schizophrenia.

    abstract::Recent years have seen an explosive growth of interest in the application of imaging genetics to understand neurogenetic mechanisms of schizophrenia. Imaging genetics applies structural and functional neuroimaging to study subjects carrying genetic risk variants that relate to a psychiatric disorder. We review selecte...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Meyer-Lindenberg A

    更新日期:2010-01-01 00:00:00

  • Treatment mechanisms: traditional and new antipsychotic drugs.

    abstract::The first generation of antipsychotic drugs was discovered in the 1960s and 1970s, These agents were effective in treating psychosis, but were accompanied by significant side effects, including severe parkinsonism and akathisia. Second-generation antipsychotics were introduced in the 1990s, These drugs have at least e...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Tamminga CA

    更新日期:2000-09-01 00:00:00

  • Cellular basis of memory for addiction.

    abstract::DESPITE THE IMPORTANCE OF NUMEROUS PSYCHOSOCIAL FACTORS, AT ITS CORE, DRUG ADDICTION INVOLVES A BIOLOGICAL PROCESS: the ability of repeated exposure to a drug of abuse to induce changes in a vulnerable brain that drive the compulsive seeking and taking of drugs, and loss of control over drug use, that define a state o...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Nestler EJ

    更新日期:2013-12-01 00:00:00

  • Genetics of generalized anxiety disorder and related traits.

    abstract::This review serves as a systematic guide to the genetics of generalized anxiety disorder (GAD) and further focuses on anxiety-relevant endophenotypes, such as pathological worry fear of uncertainty, and neuroticism. We inspect clinical genetic evidence for the familialityl heritability of GAD and cross-disorder phenot...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Gottschalk MG,Domschke K

    更新日期:2017-06-01 00:00:00

  • Epilepsy research: a window onto function to and dysfunction of the human brain.

    abstract::As one of the most common neurological disorders, epilepsy has devastating behavioral, social, and occupational consequences and is associated with accumulating brain damage and neurological deficits. Epilepsy comprises a large number of syndromes, which vary greatly with respect to their etiology and clinical feature...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Beck H,Elger CE

    更新日期:2008-01-01 00:00:00

  • Internet interventions for depression: new developments.

    abstract::A wide range of Internet interventions, mostly grounded in methods of cognitive behavioral therapy, have been developed and tested for several mental disorders. The evidence to date shows that these interventions are effective in reducing symptoms of depression. Metaanalyses report small-to-medium effect sizes when In...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Schröder J,Berger T,Westermann S,Klein JP,Moritz S

    更新日期:2016-06-01 00:00:00

  • Partial remission, residual symptoms, and relapse in depression.

    abstract::Partial remission from depression, with residual symptoms, is an important problem in depression. This paper reviews the frequency and features of this outcome, and its association with relapse. Residual symptoms occur in many depressed patients after acute treatment. They span the typical symptoms of depression, exce...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Paykel ES

    更新日期:2008-01-01 00:00:00

  • Depression and end-of-life care for patients with cancer.

    abstract::Patients with cancer and depression experience more physical symptoms, have poorer quality of life, and are more likely to have suicidal thoughts or a desire for hastened death than are cancer patients who are not depressed. Despite the ubiquity of depressive symptoms in cancer patients at the end of life, critical qu...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Rosenstein DL

    更新日期:2011-01-01 00:00:00

  • Alternative and complementary approaches in psychiatry: beliefs versus evidence.

    abstract::While the legitimacy of medical treatments is more and more questioned, one sees a paradoxical increase in nonconventional approaches, notably so in psychiatry. Over time, approaches that were considered valuable by the scientific community were found to be inefficacious, while other approaches, labelled as alternativ...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 历史文章,杂志文章,评审

    doi:

    authors: Schulz P,Hede V

    更新日期:2018-09-01 00:00:00

  • The therapeutic transnosological use of psychotropic drugs.

    abstract::The current clinical use of psychotropic drugs is transnosologically oriented. This is facilitated by the current classification of mental disorders (International Classification of Diseases, 10th Revision [ICD-10]) and is perhaps justified if depression and psychosis (taken here as examples) are considered as being c...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Ackenheil M,Montane Jaime LK

    更新日期:1999-12-01 00:00:00

  • Descriptive psychopathology, phenomenology, and the legacy of Karl Jaspers.

    abstract::With his early publications (1910-1913), Karl Jaspers created a comprehensive methodological arsenal for psychiatry, thus laying the foundation for descriptive psychopathology. Following Edmund Husserl, the founder of philosophical phenomenology, Jaspers introduced phenomenology into psychopathology as "static underst...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 传,历史文章,杂志文章

    doi:

    authors: Häfner H

    更新日期:2015-03-01 00:00:00

  • Alcoholism: the dissection for endophenotypes.

    abstract::Alcohol dependence (alcoholism) is a complex disorder attributed to the interaction of genetic and environmental factors that form a collage of "disease" predisposition, which is not identical for every alcohol-dependent individual. There is considerable evidence to demonstrate that genetic predisposition accounts for...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Hines LM,Ray L,Hutchison K,Tabakoff B

    更新日期:2005-01-01 00:00:00

  • Ethical and public policy challenges for pharmacogenomics.

    abstract::It is timely to consider the ethical and social questions raised by progress in pharmacogenomics, based on the current importance of pharmacogenomics for avoidance of predictable side effects of drugs, and for correct choice of medications in certain cancers. It has been proposed that the entire population be genotype...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Gershon ES,Alliey-Rodriguez N,Grennan K

    更新日期:2014-12-01 00:00:00

  • Applications of magnetic resonance imaging for treatment-resistant late-life depression.

    abstract::Late-life depression (LLD) is a growing public and global health concern with diverse clinical manifestations and etiology. This literature review summarizes neuroimaging findings associated with depression in older adults and treatment-response variability. LLD has been associated with cerebral atrophy, diminished my...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Agudelo C,Aizenstein HJ,Karp JF,Reynolds CF 3rd

    更新日期:2015-06-01 00:00:00

  • Pursuit of the "truth" about mental illness: the significance of findings in neuropsychiatric research, and lessons from the past.

    abstract::Technology in genetics and brain imaging has advanced so rapidly that it is difficult to be knowledgeable about all the new tools being used in the pursuit of progress toward understanding and treating mental illness. While findings from new studies remain promising, caution is needed with regard to their current appl...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 社论

    doi:

    authors: DeLisi LE

    更新日期:2014-12-01 00:00:00

  • Experimental models of stress.

    abstract::Illustrating the complexity of the stress response and its multifaceted manifestations is the leading idea of this overview of experimental paradigms used for stress induction in laboratory animals. The description of key features of models based on naturalistic stressors, pharmacological challenges, and genomic manip...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Patchev VK,Patchev AV

    更新日期:2006-01-01 00:00:00

  • Biomarkers in development of psychotropic drugs.

    abstract::Biomarkers have been receiving increasing attention, especially in the field of psychiatry In contrast to the availability of potent therapeutic tools including pharmacotherapy, psychotherapy, and biological therapies, unmet needs remain in terms of onset of action, stability of response, and further improvement of th...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Wiedemann K

    更新日期:2011-01-01 00:00:00

  • Core symptoms of major depressive disorder: relevance to diagnosis and treatment.

    abstract::The construct of major depressive disorder makes no etiological assumptions about populations with diverse symptom clusters. "Depressed mood" and "loss of interest or pleasure in nearly all activities" are core features of major depressive episode, though a strong case can be made to pay increasing attention to sympto...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Kennedy SH

    更新日期:2008-01-01 00:00:00

  • Animal models for screening anxiolytic-like drugs: a perspective.

    abstract::Contemporary biological psychiatry uses experimental animal models to increase our understanding of affective disorder pathogenesis. Modern anxiolytic drug discovery mainly targets specific pathways and molecular determinants within a single phenotypic domain. However, greater understanding of the mechanisms of action...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Bourin M

    更新日期:2015-09-01 00:00:00

  • Suicide bereavement and complicated grief.

    abstract::Losing a loved to suicide is one is one of life's most painful experiences. The feelings of loss, sadness, and loneliness experienced after any death of a loved one are often magnified in suicide survivors by feelings of quilt, confusion, rejection, shame, anger, and the effects of stigma and trauma. Furthermore, surv...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Tal Young I,Iglewicz A,Glorioso D,Lanouette N,Seay K,Ilapakurti M,Zisook S

    更新日期:2012-06-01 00:00:00

  • Lighting a path: genetic studies pinpoint neurodevelopmental mechanisms in autism and related disorders.

    abstract::In this review, we outline critical molecular processes that have been implicated by discovery of genetic mutations in autism. These mechanisms need to be mapped onto the neurodevelopment step(s) gone awry that may be associated with cause in autism. Molecular mechanisms include: (i) regulation of gene expression; (ii...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Pescosolido MF,Yang U,Sabbagh M,Morrow EM

    更新日期:2012-09-01 00:00:00

  • Nonpharmacological treatments for anxiety disorders.

    abstract::An evidence-based review of nonpharmacological treatments for anxiety disorders is presented. The vast majority of the controlled research is devoted to cognitive behavior therapy (CBT) and shows its efficiency and effectiveness in all the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) ...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Cottraux J

    更新日期:2002-09-01 00:00:00

  • Behavioral disturbances in Parkinson's disease.

    abstract::Treatment of Parkinson's disease (PD) is complex and often involves addressing behavioral changes in addition to the movement disorder. Patients with PD are susceptible to any psychiatric condition seen in the general population; some disorders, such as depression and anxiety, may result from PD-related neuropathologi...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Anderson KE

    更新日期:2004-09-01 00:00:00

  • The role of circadian clock genes in mental disorders.

    abstract::The study of molecular clock mechanisms in psychiatric disorders is gaining significant interest due to data suggesting that a misalignment between the endogenous circadian system and the sleep-wake cycle might contribute to the clinical status of patients suffering from a variety of psychiatric disorders. Sleep distu...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Lamont EW,Legault-Coutu D,Cermakian N,Boivin DB

    更新日期:2007-01-01 00:00:00

  • Research on serotonin and suicidal behavior: neuroendocrine and molecular approaches.

    abstract::We carried out two studies to test the hypothesis that altered central serotonergic function, as assessed by lower prolactin (PRL) response to fenfluramine (D-FEN), is more closely associated with suicidal behavior than a particular psychiatric diagnosis. A D-FEN test was performed in 85 major depressed inpatients, 33...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Corrêa H,Romano-Silva MA,Duval F,Campi-Azevedo AC,Lima V,Macher JP

    更新日期:2002-12-01 00:00:00

  • The impact of classification on psychopharmacology and biological psychiatry.

    abstract::Nosological classification in psychiatry, as it is currently applied, does not facilitate biological and psychopharmacological research.• Syndromal acuity has disappeared. Consequently, it is impossible to determine: (i) vi/hether a particular drug affects a particular symptom configuration; (ii) what exactly the beha...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: van Praag HM

    更新日期:1999-12-01 00:00:00

  • Medical and substance-related comorbidity in bipolar disorder: translational research and treatment opportunities.

    abstract::It is well established that individuals with bipolar disorder are differentially affected by substance-related as well as medical disorders (ie, cardiometabolic disorders, respiratory disorders, neurological disorders, and infectious diseases). Emerging evidence indicates that some comorbid conditions (eg, diabetes me...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: McIntyre RS,Nguyen HT,Soczynska JK,Lourenco MT,Woldeyohannes HO,Konarski JZ

    更新日期:2008-01-01 00:00:00

  • The neurotrophic and neuroprotective effects of psychotropic agents.

    abstract::Accumulating evidence suggests that psychotropic agents such as mood stabilizers, antidepressants, and antipsychotics realize their neurotrophic/neuroprotective effects by activating the mitogen activated protein kinase/extracellular signal-related kinase, PI3-kinase, and wingless/glycogen synthase kinase (GSK) 3 sign...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Hunsberger J,Austin DR,Henter ID,Chen G

    更新日期:2009-01-01 00:00:00

  • Biological markers for early detection and pharmacological treatment of Alzheimer's disease.

    abstract::The introduction of biological markers in the clinical management of Alzheimer's disease (AD) will not only improve diagnosis relating to early detection of neuropathology with underlying molecular mechanisms, but also provides tools for the assessment of objective treatment benefits. In this review, we identify a num...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Hampel H,Broich K,Hoessler Y,Pantel J

    更新日期:2009-01-01 00:00:00

  • The involvement of the striatum in decision making.

    abstract::Decision making has been extensively studied in the context of economics and from a group perspective, but still little is known on individual decision making. Here we discuss the different cognitive processes involved in decision making and its associated neural substrates. The putative conductors in decision making ...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Goulet-Kennedy J,Labbe S,Fecteau S

    更新日期:2016-03-01 00:00:00